The main objective of this WP is 1) to identify a method to assess the potential medical, social, economic and ethical impact of a risk stratification for patients with endocrine hypertension and 2) to test it with the trial run in WP4

The specific objectives of this WP are to:

1. To systematic review of the literature, identification of stakeholders, tools and methods used in the assessment of stratified medicine
2. To identify the knowledge gap with reference to the EUNetHTA core models
3. To list the markers that have shown good potential for stratification (HR >3.5) and can be used in clinical studies
4. To provide a roadmap for validation studies
5. To provide an economic evaluation of the stratified approach